A case report of dasatinib-induced tumor lysis syndrome.
10.3760/cma.j.issn.0253-2727.2014.05.027
- Author:
Huarong ZHOU
1
;
Jianzhen SHEN
1
Author Information
1. Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China.
- Publication Type:Case Reports
- MeSH:
Dasatinib;
Humans;
Pyrimidines;
adverse effects;
Thiazoles;
adverse effects;
Tumor Lysis Syndrome;
etiology
- From:
Chinese Journal of Hematology
2014;35(5):480-480
- CountryChina
- Language:Chinese